Dr. Slosky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-1530Fax+1 608-265-8887
Summary
- Dr. David Slosky is a Cardiovascular Oncologist in Nashville, TN and is a retired faculty member at Vanderbilt Medical Center and works part time @ the University of Wisconsin Medical Center in Madison, Wisconsin. He is a clinical Assistant Professor of Medicine. He received his medical degree from University of Colorado School of Medicine and has been in practice for more than 30years. He specializes in cardiovascular oncology and is experienced in cardiac catheterization, healthcare quality, and amyloidosis and clonal heamatopoiesis of indeterminate potential (CHIP)
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1978 - 1981- Duke University HospitalResidency, Internal Medicine, 1976 - 1978
University of Colorado School of Medicine Anschutz Medical CampusClass of 1976, MD
Certifications & Licensure
TN State Medical License 2005 - 2026
DE State Medical License 2023 - 2025
KY State Medical License 2024 - 2025
WI State Medical License 1981 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow Society of Cardiovascular Angiography & Interventions SCAI, 2007
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis.Tamanna Haque, Aditi Shastri, Pinkal Desai, Zhuoer Xie, Danielle Hammond
British Journal of Haematology. 2024-12-09 - COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.Melissa Y Y Moey, Cassandra Hennessy, Benjamin French, Jeremy L Warner, Matthew D Tucker
Translational Oncology. 2023-08-01 - 20 citationsA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.Maheen Z. Abidi, David M. Aboulafia, Melissa K. Accordino, Jared D. Acoba, Manmeet Ahluwalia
Cancer Cell. 2020-12-14
Press Mentions
Keeping Cancer Drugs from Causing Heart DamageMay 18th, 2016- Cancer Treatments Can Be Tough on the HeartApril 1st, 2016
Drug Might Help Breast Cancer Patients Avoid Heart DamageNovember 11th, 2015- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Industry Relationships
- Chief Medical Officer, Rare Disease Data Trust2023 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
